3rd CIMT Endeavour Workshop May 12, 2015 from 07:30 – 12:00 Rheingoldhalle Congress Center Mainz Rheinstraße 66, 55116 Mainz | Germany CIMT Endeavour 2015 Program 07:30 – 08:00 Registration / Welcome Snack 08:00– 08:10 Welcome Dr. Björn-Philipp Kloke, CIMT 08:10 – 09:20 Session 1: From Science to Products – Change of Perspectives Chair: Dr. Harpreet Singh, immatics CIMT-Scientist Presentation: 10 min + 25 min Prof. Richard Kroczek, Robert Koch-Institut „I nduction of massive antigen-specific CD8+ T cell cytotoxicity by targeting of antigen into XCR1+ DC combined with potent amplification regimes“ 10 min + 25 min Dr. Sebastian Kobold, Klinikum der Ludwig-Maximilians-Universität Expert Advice Panel: Discussion of abstracts Dr. Ute Fink, Project Manager, Project Management Jülich Dr. Thomas Hanke, Head of Immunology and Inflammation, Evotec Michael Kring, Managing Director, High Tech Corporate Services GmbH Dr. Ioannis Sapountzis, Global Head of Oncology Business Development & Licensing, Boehringer Ingelheim GmbH Dr. Rainer Wessel, Director, Ci3 Cluster „A new fusion receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy“ 09:20 – 09:50 Coffee break 09:50 – 10:40 Session 2: Company Story/Successful Deals Chair: Dr. Jutta Heix, Oslo Cancer Cluster 20 min + 5 min 20 min + 5 min Dr. Øyvind Arnesen, CEO, Ultimovacs AS Prof. Dr. Dolores J. Schendel, CSO, Medigene AG 10:40– 11:00 Coffee break 11:00 – 11:45 Session 3: What Entrepreneurs in Europe Face Chair: Dr. Cedrik M. Britten, GSK 40 min + 5 min Key Note Dr. Claus Kremoser, Managing Director, Phenex Pharmaceuticals AG 11:45 – 12:00 Closing Words Dr. Cedrik M. Britten, CIMT Sponsored by the: In cooperation with:
© Copyright 2024